Carbapenemase-producing Pseudomonas aeruginosa in UK

Lancet. 1998 Aug 15;352(9127):546-7. doi: 10.1016/s0140-6736(05)79255-2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amikacin / pharmacology
  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents / pharmacology
  • Bacterial Proteins*
  • Carbapenems / pharmacology
  • Ceftazidime / pharmacology
  • Ciprofloxacin / pharmacology
  • Drug Resistance, Microbial
  • Enzyme Inhibitors / pharmacology
  • Gentamicins / pharmacology
  • Humans
  • Imipenem / pharmacology
  • Meropenem
  • Metalloproteins / analysis
  • Metalloproteins / metabolism*
  • Penicillanic Acid / analogs & derivatives
  • Penicillanic Acid / pharmacology
  • Penicillins / pharmacology
  • Piperacillin / pharmacology
  • Pseudomonas aeruginosa / drug effects
  • Pseudomonas aeruginosa / enzymology*
  • Pseudomonas aeruginosa / isolation & purification
  • Tazobactam
  • Thienamycins / pharmacology
  • United Kingdom
  • beta-Lactam Resistance
  • beta-Lactamase Inhibitors
  • beta-Lactamases / analysis
  • beta-Lactamases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Bacterial Proteins
  • Carbapenems
  • Enzyme Inhibitors
  • Gentamicins
  • Metalloproteins
  • Penicillins
  • Thienamycins
  • beta-Lactamase Inhibitors
  • Ciprofloxacin
  • Imipenem
  • Amikacin
  • Penicillanic Acid
  • Ceftazidime
  • beta-Lactamases
  • carbapenemase
  • Meropenem
  • Tazobactam
  • Piperacillin